Hoffman William's Form 4 filing
Inari Medical, Inc. (NARI) · filed Oct 19, 2022
- Accession no.
- 0001127602-22-024164
- Filed
- Oct 19, 2022
- Trade date
- Oct 17, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 14 non-derivative transactions and 0 derivative transactions. Open-market sales total $4.18M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Hoffman WilliamCIK 0001304099 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 17, 2022 | Common Stock | SSaleDisposed | −1,100 | $72.76 | −$80,036 | 346,381 | Direct | |
| Oct 17, 2022 | Common Stock | SSaleDisposed | −1,232 | $74.75 | −$92,092 | 345,149 | Direct | |
| Oct 17, 2022 | Common Stock | SSaleDisposed | −12,751 | $75.51 | −$962,828.01 | 332,398 | Direct | |
| Oct 17, 2022 | Common Stock | SSaleDisposed | −13,986 | $76.22 | −$1,066,012.92 | 318,412 | Direct | |
| Oct 17, 2022 | Common Stock | SSaleDisposed | −5,931 | $77.05 | −$456,983.55 | 312,481 | Direct | |
| Oct 17, 2022 | Common Stock | SSaleDisposed | −500 | $72.71 | −$36,355 | 311,981 | Direct | |
| Oct 17, 2022 | Common Stock | SSaleDisposed | −600 | $74.70 | −$44,820 | 311,381 | Direct | |
| Oct 17, 2022 | Common Stock | SSaleDisposed | −6,225 | $76.56 | −$476,586 | 305,156 | Direct | |
| Oct 17, 2022 | Common Stock | SSaleDisposed | −6,122 | $76.38 | −$467,598.36 | 299,034 | Direct | |
| Oct 17, 2022 | Common Stock | SSaleDisposed | −1,553 | $77.08 | −$119,705.24 | 297,481 | Direct | |
| Oct 17, 2022 | Common Stock | SSaleDisposed | −200 | $72.85 | −$14,570 | 297,281 | Direct | |
| Oct 17, 2022 | Common Stock | SSaleDisposed | −400 | $74.83 | −$29,932 | 296,881 | Direct | |
| Oct 17, 2022 | Common Stock | SSaleDisposed | −2,761 | $75.84 | −$209,394.24 | 294,120 | Direct | |
| Oct 17, 2022 | Common Stock | SSaleDisposed | −1,639 | $76.64 | −$125,612.96 | 292,481 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.